MedPath

OPTREX EYE LOTION

OPTREX EYE LOTION

Discontinued
DIN Number

00520101

Drug Class

Human

Market Date

Dec 31, 1981

Company
HC

optrex labs ltd.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number00520101
AIG Number0612388001
Classification & Schedule
C
Drug Class
Human
S
Schedule
OTC
A
ATC Code
S01AX07 SODIUM BORATE
Product Specifications
Dosage FormLiquid
Route of AdministrationOphthalmic
AHFS Classification52:04.92
Health Canada Classification

ACTIVE INGREDIENTS (6)

ALLANTOINActive
Strength: .05 %
Monograph: ALLANTOIN
BORIC ACIDActive
Strength: 2 %
Monograph: BORIC ACID
HAMAMELIS VIRGINIANAActive
Strength: 12.95 %
Monograph: HAMAMELIS VIRGINIANA
SALICYLIC ACIDActive
Strength: .025 %
Monograph: SALICYLIC ACID
SODIUM BORATEActive
Strength: .5 %
Monograph: SODIUM BORATE
ZINC SULFATEActive
Strength: .004 %
Monograph: ZINC SULFATE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.